Cargando…

Response to: “Does ACPA-negative RA consist of subgroups related to sustained DMARD-free remission and serological markers at disease presentation” by Masi and Fleischmann

Detalles Bibliográficos
Autores principales:	Boeters, Debbie M., van der Helm–van Mil, Annette H. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082976/ https://www.ncbi.nlm.nih.gov/pubmed/32197624 http://dx.doi.org/10.1186/s13075-020-02152-9

Ejemplares similares

Correction to: Response to: “Does ACPA-negative RA consist of subgroups related to sustained DMARD-free remission and serological markers at disease presentation” by Masi and Fleischmann
por: Boeters, Debbie M., et al.
Publicado: (2020)

ACPA-negative RA consists of subgroups: patients with high likelihood of achieving sustained DMARD-free remission can be identified by serological markers at disease presentation
por: Boeters, Debbie M., et al.
Publicado: (2019)

Does ACPA-negative RA consist of subgroups related to sustained DMARD-free remission and serological markers at disease presentation? Comment on article by Boeters DM et al.
por: Masi, Alfonse T., et al.
Publicado: (2020)

Unraveling heterogeneity within ACPA-negative rheumatoid arthritis: the subgroup of patients with a strong clinical and serological response to initiation of DMARD treatment favor disease resolution
por: Verstappen, M., et al.
Publicado: (2022)

MRI-detected osteitis is not associated with the presence or level of ACPA alone, but with the combined presence of ACPA and RF
por: Boeters, Debbie M., et al.
Publicado: (2016)

ACPA-negative and ACPA-positive RA patients achieving disease resolution demonstrate distinct patterns of MRI-detected joint-inflammation
por: Verstappen, Marloes, et al.
Publicado: (2022)

The prevalence of ACPA is lower in rheumatoid arthritis patients with an older age of onset but the composition of the ACPA response appears identical
por: Boeters, Debbie M., et al.
Publicado: (2017)

Early DAS response after DMARD-start increases probability of achieving sustained DMARD-free remission in rheumatoid arthritis
por: Verstappen, M., et al.
Publicado: (2020)

Differing time-orders of inflammation decrease between ACPA subsets in RA patients suggest differences in underlying inflammatory pathways
por: Matthijssen, Xanthe M E, et al.
Publicado: (2020)

Tapering towards DMARD-free remission in established rheumatoid arthritis: 2-year results of the TARA trial
por: van Mulligen, Elise, et al.
Publicado: (2020)

DMARD-free remission as novel treatment target in rheumatoid arthritis: A systematic literature review of achievability and sustainability
por: Verstappen, M, et al.
Publicado: (2020)

Does treatment strategy influence the ability to achieve and sustain DMARD-free remission in patients with RA? Results of an observational study comparing an intensified DAS-steered treatment strategy with treat to target in routine care
por: Burgers, L. E., et al.
Publicado: (2019)

A search to the target tissue in which RA-specific inflammation starts: a detailed MRI study to improve identification of RA-specific features in the phase of clinically suspect arthralgia
por: Matthijssen, Xanthe M. E., et al.
Publicado: (2019)

ACPA-Negative RA Consists of Two Genetically Distinct Subsets Based on RF Positivity in Japanese
por: Terao, Chikashi, et al.
Publicado: (2012)

ACPA-positive and ACPA-negative rheumatoid arthritis differ in their requirements for combination DMARDs and corticosteroids: secondary analysis of a randomized controlled trial
por: Seegobin, Seth D, et al.
Publicado: (2014)

Which patients presenting with arthralgia eventually develop rheumatoid arthritis? The current state of the art
por: Boeters, Debbie M, et al.
Publicado: (2017)

Ways forward to identify new ACPA targets in RA
por: Ytterberg, A Jimmy, et al.
Publicado: (2012)

Does the presence of magnetic resonance imaging-detected osteitis at diagnosis with rheumatoid arthritis lower the risk for achieving disease-modifying antirheumatic drug-free sustained remission: results of a longitudinal study
por: Burgers, L. E., et al.
Publicado: (2018)

Substitution of the quantitative serological component in the 2010 criteria for RA with qualitative presence of three autoantibodies yields similar performance: response to the article by Regueiro et al.
por: van Dijk, Bastiaan T., et al.
Publicado: (2020)

An investigation of the added value of an ACPA multiplex assay in an early rheumatoid arthritis setting
por: van Heemst, Jurgen, et al.
Publicado: (2015)

MASiVEdb: the Sirevirus Plant Retrotransposon Database
por: Bousios, Alexandros, et al.
Publicado: (2012)

MASI: microbiota—active substance interactions database
por: Zeng, Xian, et al.
Publicado: (2020)

The earlier, the better or the worse? Towards accurate management of patients with arthralgia at risk for RA
por: van der Helm-van Mil, Annette, et al.
Publicado: (2020)

Does information on novel identified autoantibodies contribute to predicting the progression from undifferentiated arthritis to rheumatoid arthritis: a study on anti-CarP antibodies as an example
por: Boeters, Debbie M., et al.
Publicado: (2018)

Inflammation functions as a key mediator in the link between ACPA and erosion development: an association study in Clinically Suspect Arthralgia
por: ten Brinck, R. M., et al.
Publicado: (2018)

Improvement of symptoms in clinically suspect arthralgia and resolution of subclinical joint inflammation: a longitudinal study in patients that did not progress to clinical arthritis
por: ten Brinck, Robin M., et al.
Publicado: (2020)

The value of the squeeze test for detection of subclinical synovitis in patients with arthralgia suspicious for progression to RA
por: Wouters, Fenne, et al.
Publicado: (2020)

Patients with ACPA-positive and ACPA-negative rheumatoid arthritis show different serological autoantibody repertoires and autoantibody associations with disease activity
por: Cunningham, Kevin Y., et al.
Publicado: (2023)

ACPA fine-specificity profiles in early rheumatoid arthritis patients do not correlate with clinical features at baseline or with disease progression
por: van Beers, Joyce JBC, et al.
Publicado: (2013)

Platelets derived citrullinated proteins and microparticles are potential autoantibodies ACPA targets in RA patients
por: Xu, Minjie, et al.
Publicado: (2023)

Joint involvement in RA starts predominantly in the hands: functional, clinical and imaging studies in clinically suspect arthralgia and during progression to RA
por: Khidir, Sarah J H, et al.
Publicado: (2023)

The relation between physical joint examination and MRI-depicted inflammation of metatarsophalangeal joints in early arthritis
por: Dakkak, Yousra J., et al.
Publicado: (2020)

Comments on "Claims of excess enthalpy by Fleischmann and Pons using simple cells made to boil"
por: Morrison, Douglas Robert Ogston
Publicado: (1993)

Anti-citrullinated peptide/protein antibody (ACPA)-negative RA shares a large proportion of susceptibility loci with ACPA-positive RA: a meta-analysis of genome-wide association study in a Japanese population
por: Terao, Chikashi, et al.
Publicado: (2015)

Immunoprofiling of early, untreated rheumatoid arthritis using mass cytometry reveals an activated basophil subset inversely linked to ACPA status
por: Koppejan, H., et al.
Publicado: (2021)

Revision of Paranastatus Masi (Eupelmidae, Eupelminae) with descriptions of four new species
por: Scallion, Melanie L., et al.
Publicado: (2016)

Work participation is reduced during the development of RA, months before clinical arthritis manifests
por: Rogier, Cleo, et al.
Publicado: (2021)

Prediction of sustained biologic and targeted synthetic DMARD-free remission in rheumatoid arthritis patients
por: Burkard, Theresa, et al.
Publicado: (2021)

Can anti-cyclic citrullinated peptide antibody-negative RA be subdivided into clinical subphenotypes?
por: De Rooy, Diederik PC, et al.
Publicado: (2011)

Aspects of early arthritis. Definition of disease states in early arthritis: remission versus minimal disease activity
por: van der Helm-van Mil, Annette HM, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_hnnoqa9vhu2rdfhe0nbfhkbu04